REGULATORY INTELLIGENCE·Recall
Aurobindo Pharma's Clozapine Recall: Foreign Tablet Contamination Exposes Critical Supply Chain Vulnerabilities
Aurobindo Pharma USA Inc. initiated a Class II recall for 1,440 bottles of Clozapine Tablets USP 100mg due to foreign tablet contamination. This event, now terminated, highlights critical quality control vulnerabilities in pharmaceutical manufacturing and distribution. Procurement and regulatory teams must scrutinize supplier quality systems, particularly for generic antipsychotics like Clozapine, to safeguard patient safety and ensure supply chain integrity against similar deviations.
90-Day Activity